[(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate

C44H63N5O11 — CID 22770988

IUPAC[(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate
SMILESCC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC(=O)NC/C=C/c2ccc(-c3ccn(C)n3)cc2)C[C@@H](C)C(=O)[C@H](C)[C@@H]2NC(=O)O[C@]12C
InChIInChI=1S/C44H63N5O11/c1-12-33-44(8)37(46-42(55)60-44)26(4)34(50)24(2)23-43(7,59-41(54)45-20-13-14-29-15-17-30(18-16-29)31-19-21-49(11)47-31)38(27(5)35(51)28(6)39(53)57-33)58-40-36(52)32(48(9)10)22-25(3)56-40/h13-19,21,24-28,32-33,36-38,40,52H,12,20,22-23H2,1-11H3,(H,45,54)(H,46,55)/b14-13+/t24-,25-,26+,27+,28-,32+,33-,36-,37+,38-,40+,43-,44-/m1/s1
InChIKeyWJNBAHHXFKDUMH-QXZRMADCSA-N
MW838.01 g/mol
LogP4.67
Rot. Bonds9

About [(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate

[(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate (PubChem CID 22770988) has the molecular formula C44H63N5O11 and a molecular weight of 838.01 g/mol. Its IUPAC name is [(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate.

Molecular Properties

Compound Name[(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate
PubChem CID22770988
Molecular FormulaC44H63N5O11
Molecular Weight838.01 g/mol
Exact Mass837.45
IUPAC Name[(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate
SMILESCC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC(=O)NC/C=C/c2ccc(-c3ccn(C)n3)cc2)C[C@@H](C)C(=O)[C@H](C)[C@@H]2NC(=O)O[C@]12C
InChIInChI=1S/C44H63N5O11/c1-12-33-44(8)37(46-42(55)60-44)26(4)34(50)24(2)23-43(7,59-41(54)45-20-13-14-29-15-17-30(18-16-29)31-19-21-49(11)47-31)38(27(5)35(51)28(6)39(53)57-33)58-40-36(52)32(48(9)10)22-25(3)56-40/h13-19,21,24-28,32-33,36-38,40,52H,12,20,22-23H2,1-11H3,(H,45,54)(H,46,55)/b14-13+/t24-,25-,26+,27+,28-,32+,33-,36-,37+,38-,40+,43-,44-/m1/s1
InChIKeyWJNBAHHXFKDUMH-QXZRMADCSA-N
XLogP4.67
TPSA196.85 Ų
H-Bond Donors3
H-Bond Acceptors14
Rotatable Bonds9
Heavy Atoms60
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500838.01
LogP ≤ 54.67
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze [(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate?
The IUPAC name of [(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate (CID 22770988) is [(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate.
What is the SMILES notation for [(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate?
The canonical SMILES for [(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate is CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC(=O)NC/C=C/c2ccc(-c3ccn(C)n3)cc2)C[C@@H](C)C(=O)[C@H](C)[C@@H]2NC(=O)O[C@]12C.
What is the InChIKey of [(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate?
The InChIKey is WJNBAHHXFKDUMH-QXZRMADCSA-N. The full InChI is InChI=1S/C44H63N5O11/c1-12-33-44(8)37(46-42(55)60-44)26(4)34(50)24(2)23-43(7,59-41(54)45-20-13-14-29-15-17-30(18-16-29)31-19-21-49(11)47-31)38(27(5)35(51)28(6)39(53)57-33)58-40-36(52)32(48(9)10)22-25(3)56-40/h13-19,21,24-28,32-33,36-38,40,52H,12,20,22-23H2,1-11H3,(H,45,54)(H,46,55)/b14-13+/t24-,25-,26+,27+,28-,32+,33-,36-,37+,38-,40+,43-,44-/m1/s1.
What are the key properties of [(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate?
[(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate has a molecular weight of 838.01 g/mol, XLogP of 4.67, 9 rotatable bonds, 3 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,2R,5R,7R,8R,9R,11R,13R,14S)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-9-yl] N-[(E)-3-[4-(1-methylpyrazol-3-yl)phenyl]prop-2-enyl]carbamate is sourced from PubChem (CID 22770988), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).